In summary, this is the first study to systematically interrogate the functional and clinical significance of UCA1 in prostate cancer, and we provide comprehensive evidence that it acts as a novel oncogenic lncRNA in PCa. This evidence concerns the gene UCA1 and prostate carcinoma.